Villhard grew Second Street at the same time he was working toward his EMBA at Olin.
have received Frontiers of Imaging grants from the Chan Zuckerberg Initiative to further their research on biomedical imaging.
Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.
In the video, they demonstrate their breakthrough AR technology that visualizes a patient’s heart in 3D during surgery.
A recent article in the St. Louis Post-Dispatch examines research from WashU innovator Hong Chen.
Two members of the Washington University in St. Louis community have been named National Academy of Inventors fellows.
St. Louis-based startup Takoda uses data to help monitor treatment and recovery of substance use disorders.
As editor-in-chief, Thorp will be one of the most significant voices in the global conversation about research and scientific discovery.
Olin welcomes Doug Villhard as the new academic director for entrepreneurship.